Rafferty Asset Management, LLC Anavex Life Sciences Corp. Transaction History
Rafferty Asset Management, LLC
- $29.4 Billion
- Q2 2025
A detailed history of Rafferty Asset Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 92,144 shares of AVXL stock, worth $830,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,144
Previous 127,454
27.7%
Holding current value
$830,217
Previous $1.09 Million
22.32%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AVXL
# of Institutions
196Shares Held
32MCall Options Held
1.16MPut Options Held
804K-
Black Rock Inc. New York, NY6.39MShares$57.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$46 Million0.0% of portfolio
-
State Street Corp Boston, MA2.95MShares$26.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$18.2 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1.02MShares$9.23 Million0.83% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $702M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...